| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27,3 M € | -16.4% | 32,7 M € | -35.5% | 50,7 M € | +41.2% | 35,9 M € | +128.4% | 15,7 M € | -43.4% | 27,8 M € | +60.1% | 17,4 M € | +61.9% | 10,7 M € | +70.4% | 6,3 M € | +67.0% | 3,8 M € | +159.4% | 1,5 M € | +495.3% | 243,9 k € | — | ||
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | -54,3 k € | |||||||||||||
| EBITDA | -17,1 M € | +5.6% | -18,1 M € | -552.7% | -2,8 M € | -1.9% | -2,7 M € | -179.5% | 3,4 M € | -5.9% | 3,6 M € | -45.4% | 6,7 M € | +56.9% | 4,3 M € | +178.8% | 1,5 M € | +199.4% | -1,5 M € | +4.1% | -1,6 M € | +2.4% | -1,6 M € | -191.2% | -564,0 k € | |
| Operating profit | -23,0 M € | +5.6% | -24,3 M € | -294.3% | -6,2 M € | -1.5% | -6,1 M € | -748.2% | 937,3 k € | +332.9% | -402,5 k € | -110.1% | 4,0 M € | +54.5% | 2,6 M € | +4700.7% | -56,1 k € | +97.7% | -2,4 M € | -6.4% | -2,3 M € | -0.7% | -2,3 M € | -113.6% | -1,1 M € | |
| Profit/loss | -32,0 M € | -8.5% | -29,5 M € | -219.9% | -9,2 M € | -37.9% | -6,7 M € | -804.9% | 947,3 k € | +316.5% | -437,6 k € | -111.8% | 3,7 M € | +53.9% | 2,4 M € | +710.3% | -394,4 k € | +84.8% | -2,6 M € | -10.0% | -2,4 M € | -5.5% | -2,2 M € | -129.6% | -977,2 k € | |
| Equity | 53,7 M € | +272.8% | -31,1 M € | -2037.1% | -1,5 M € | -118.3% | 8,0 M € | -47.0% | 15,0 M € | +5.2% | 14,3 M € | +7.3% | 13,3 M € | +36.2% | 9,8 M € | +2573.0% | 365,7 k € | +127.7% | -1,3 M € | +41.8% | -2,3 M € | -793.1% | -253,7 k € | -113.4% | 1,9 M € | |
| Total assets | 183,6 M € | +8.1% | 169,8 M € | +11.7% | 152,0 M € | +29.1% | 117,8 M € | +251.3% | 33,5 M € | +13.6% | 29,5 M € | +25.0% | 23,6 M € | +36.3% | 17,3 M € | +57.8% | 11,0 M € | +40.1% | 7,8 M € | +51.4% | 5,2 M € | +14.3% | 4,5 M € | -17.1% | 5,5 M € | |
| Cash | 1,1 M € | +16.5% | 980,9 k € | -57.0% | 2,3 M € | +99.9% | 1,1 M € | -64.9% | 3,2 M € | -30.7% | 4,7 M € | +60.0% | 2,9 M € | +19.6% | 2,4 M € | +229.8% | 742,9 k € | -31.1% | 1,1 M € | +190.3% | 371,4 k € | +145.1% | 151,5 k € | -81.7% | 829,2 k € | |
| Debts | 126,8 M € | -34.7% | 194,1 M € | +30.9% | 148,4 M € | +40.4% | 105,7 M € | +529.5% | 16,8 M € | +36.0% | 12,3 M € | +36.1% | 9,1 M € | +34.1% | 6,8 M € | -29.2% | 9,5 M € | +22.3% | 7,8 M € | +18.6% | 6,6 M € | +54.5% | 4,3 M € | +19.0% | 3,6 M € | |
| Staff | 229,6 | 319,1 | 311,1 | 236,3 | 208,1 | 175,3 | 114 | 83,3 | 68 | 35,8 | 19,1 | 12,6 | 6,3 | |||||||||||||
Public limited company · Charleroi · incorporated on 07/11/2011 · 229,6 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+16.5%).
Solid counterparty for a standard engagement.
Catalent Gosselies is a Public limited company incorporated in 2011. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Charleroi. It employs on average 229,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette